Quick Answer
Mereo BioPharma Group plc reported Net Income of -$41.88 million for fiscal year 2025.
Mereo BioPharma Group plc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$41.88M | +3.2% |
| 2024 | -$43.25M | -46.8% |
| 2023 | -$29.47M | +30.2% |
| 2022 | -$42.22M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.02M | +53.2% | +51.9% |
| June 30, 2025 | -$14.62M | -19.3% | -13.4% |
| March 31, 2025 | -$12.89M | -44.0% | +14.1% |
| September 30, 2024 | -$15.00M | -129.7% | -22.4% |
| June 30, 2024 | -$12.26M | -599.9% | -36.9% |
| March 31, 2024 | -$8.95M | +25.9% | -37.1% |
| September 30, 2023 | -$6.53M | — | -273.0% |
| June 30, 2023 | -$1.75M | — | +85.5% |
- Mereo BioPharma Group plc showed an increase of +3.2% in Net Income compared to the prior fiscal year.
- Over the 2022–2025 period, Mereo BioPharma Group plc’s net income has grown by 0.8% (from -$42.22 million to -$41.88 million).
- The most recent figure is from Mereo BioPharma Group plc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: